2026 LTC Pharmacy M&A Special Report
The long-term care pharmacy sector is undergoing meaningful transformation, supported by favorable demographic trends, evolving care models and continued healthcare[...]
MoreThe long-term care pharmacy sector is undergoing meaningful transformation, supported by favorable demographic trends, evolving care models and continued healthcare[...]
MoreCompounding pharmacy remains a sector that competes on innovation, clinical value, and service—not price. Businesses that compete primarily on price[...]
MoreOther private equity investors might acquire a target to enhance their purchasing power. For example, in the case of a[...]
MoreIn my 2023 Market Outlook Report I wrote about how marginalized patient populations and economic inflation can impact pharmacy values.[...]
MoreThis year is a dynamic and fast-paced one for compounding pharmacy M&A. Early in the year, unpredictability in the broader[...]
MoreLTC Pharmacy underwent more disruption and change in just the past few years than the preceding decades. Revenue models morphed,[...]
MoreThe healthcare services sector continues to attract attention from buyers across a broad range of backgrounds. While late 2021 and[...]
MoreThe healthcare services sector continues to attract attention from buyers across a broad range of backgrounds. While late 2021 and[...]
MoreWhat’s driving the interest in compounding pharmacy? Disruption, growth and industry architecture. First, acquirers are aggressively seeking to establish boots[...]
MoreIf you are reading this, you’re likely seeking an answer to the popular question: “How has the pandemic impacted the[...]
More